Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Feb;78(916):63–70. doi: 10.1136/pmj.78.916.63

Subacute sclerosing panencephalitis

R Garg 1
PMCID: PMC1742261  PMID: 11807185

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence. It is caused by persistent defective measles virus. Brain biopsies or postmortem histopathological examination show evidence of astrogliosis, neuronal loss, degeneration of dendrites, demyelination, neurofibrillary tangles, and infiltration of inflammatory cells. Patients usually have behavioral changes, myoclonus, dementia, visual disturbances, and pyramidal and extrapyramidal signs. The disease has a gradual progressive course leading to death within 1-3 years. The diagnosis is based upon characteristic clinical manifestations, the presence of characteristic periodic EEG discharges, and demonstration of raised antibody titre against measles in the plasma and cerebrospinal fluid. Treatment for SSPE is still undetermined. A combination of oral isoprinosine (Inosiplex) and intraventricular interferon alfa appears to be the best effective treatment. Patients responding to treatment need to receive it life long. Effective immunisation against measles is the only solution presently available to the problem of this dreaded disease.

Full Text

The Full Text of this article is available as a PDF (171.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaby P., Bukh J., Lisse I. M., Smits A. J. Risk factors in subacute sclerosing panencephalitis: age- and sex-dependent host reactions or intensive exposure? Rev Infect Dis. 1984 Mar-Apr;6(2):239–250. doi: 10.1093/clinids/6.2.239. [DOI] [PubMed] [Google Scholar]
  2. Abdelnoor A. M., Dhib-Jalbut S. S., Haddad F. S. Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis. J Neuroimmunol. 1982 Jan;2(1):27–34. doi: 10.1016/0165-5728(82)90073-x. [DOI] [PubMed] [Google Scholar]
  3. Alexander M., Singh S., Gnanamuthu C., Chandi S., Korah I. P. Subacute sclerosing panencephalitis : CT and MR imaging in a rapidly progressive case. Neurol India. 1999 Dec;47(4):304–307. [PubMed] [Google Scholar]
  4. Allen I. V., McQuaid S., McMahon J., Kirk J., McConnell R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol. 1996 Apr;55(4):471–480. doi: 10.1097/00005072-199604000-00010. [DOI] [PubMed] [Google Scholar]
  5. Anlar B., Gücüyener K., Imir T., Yalaz K., Renda Y. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study. Pediatr Infect Dis J. 1993 Jul;12(7):578–581. doi: 10.1097/00006454-199307000-00006. [DOI] [PubMed] [Google Scholar]
  6. Anlar B., Saatçi I., Köse G., Yalaz K. MRI findings in subacute sclerosing panencephalitis. Neurology. 1996 Nov;47(5):1278–1283. doi: 10.1212/wnl.47.5.1278. [DOI] [PubMed] [Google Scholar]
  7. Anlar B., Söylemezoğlu F., Elibol B., Dalkara T., Aysun S., Köse G., Belen D., Yalaz K. Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients. Neuropediatrics. 1999 Oct;30(5):239–242. doi: 10.1055/s-2007-973497. [DOI] [PubMed] [Google Scholar]
  8. Anlar B., Yalaz K., Köse G., Saygi S. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol. 1998 Nov;13(11):557–559. doi: 10.1177/088307389801301106. [DOI] [PubMed] [Google Scholar]
  9. Anlar B., Yalaz K., Oktem F., Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology. 1997 Feb;48(2):526–528. doi: 10.1212/wnl.48.2.526. [DOI] [PubMed] [Google Scholar]
  10. Baczko K., Lampe J., Liebert U. G., Brinckmann U., ter Meulen V., Pardowitz I., Budka H., Cosby S. L., Isserte S., Rima B. K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology. 1993 Nov;197(1):188–195. doi: 10.1006/viro.1993.1579. [DOI] [PubMed] [Google Scholar]
  11. Ballart I., Huber M., Schmid A., Cattaneo R., Billeter M. A. Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol. 1991 Jun;65(6):3161–3166. doi: 10.1128/jvi.65.6.3161-3166.1991. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  12. Billeter M. A., Cattaneo R., Spielhofer P., Kaelin K., Huber M., Schmid A., Baczko K., ter Meulen V. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci. 1994 Jun 6;724:367–377. doi: 10.1111/j.1749-6632.1994.tb38934.x. [DOI] [PubMed] [Google Scholar]
  13. Brismar J., Gascon G. G., von Steyern K. V., Bohlega S. Subacute sclerosing panencephalitis: evaluation with CT and MR. AJNR Am J Neuroradiol. 1996 Apr;17(4):761–772. [PMC free article] [PubMed] [Google Scholar]
  14. Brown H. R., Goller N. L., Rudelli R. D., Dymecki J., Wisniewski H. M. Postmortem detection of measles virus in non-neural tissues in subacute sclerosing panencephalitis. Ann Neurol. 1989 Aug;26(2):263–268. doi: 10.1002/ana.410260213. [DOI] [PubMed] [Google Scholar]
  15. Campoli-Richards D. M., Sorkin E. M., Heel R. C. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1986 Nov;32(5):383–424. doi: 10.2165/00003495-198632050-00001. [DOI] [PubMed] [Google Scholar]
  16. Carter M. J., Willcocks M. M., ter Meulen V. Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature. 1983 Sep 8;305(5930):153–155. doi: 10.1038/305153a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1998. A 34-year-old woman with confusion and visual loss during pregnancy. N Engl J Med. 1998 May 14;338(20):1448–1456. doi: 10.1056/NEJM199805143382008. [DOI] [PubMed] [Google Scholar]
  18. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25-1986. A 24-year-old woman with a three-month history of progressive mental deterioration. N Engl J Med. 1986 Jun 26;314(26):1689–1700. doi: 10.1056/NEJM198606263142607. [DOI] [PubMed] [Google Scholar]
  19. Cathomen T., Naim H. Y., Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol. 1998 Feb;72(2):1224–1234. doi: 10.1128/jvi.72.2.1224-1234.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cattaneo R., Rose J. K. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol. 1993 Mar;67(3):1493–1502. doi: 10.1128/jvi.67.3.1493-1502.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cattaneo R., Schmid A., Spielhofer P., Kaelin K., Baczko K., ter Meulen V., Pardowitz J., Flanagan S., Rima B. K., Udem S. A. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology. 1989 Dec;173(2):415–425. doi: 10.1016/0042-6822(89)90554-0. [DOI] [PubMed] [Google Scholar]
  22. Cianchetti C., Fratta A. L., Muntoni F., Marrosu G., Marrosu M. G. Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis. Ital J Neurol Sci. 1994 Apr;15(3):153–155. doi: 10.1007/BF02339207. [DOI] [PubMed] [Google Scholar]
  23. Cianchetti C., Marrosu M. G., Muntoni F., Fratta A., Zuddas A. Intraventricular alpha-interferon in subacute sclerosing panencephalitis. Neurology. 1998 Jan;50(1):315–316. doi: 10.1212/wnl.50.1.315. [DOI] [PubMed] [Google Scholar]
  24. Dawson J. R. Cellular Inclusions in Cerebral Lesions of Lethargic Encephalitis. Am J Pathol. 1933 Jan;9(1):7–16.3. [PMC free article] [PubMed] [Google Scholar]
  25. Dimova P., Bojinova V. Subacute sclerosing panencephalitis with atypical onset: clinical, computed tomographic, and magnetic resonance imaging correlations. J Child Neurol. 2000 Apr;15(4):258–260. doi: 10.1177/088307380001500411. [DOI] [PubMed] [Google Scholar]
  26. Dyken P. R., Cunningham S. C., Ward L. C. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurol. 1989 Nov-Dec;5(6):339–341. doi: 10.1016/0887-8994(89)90045-3. [DOI] [PubMed] [Google Scholar]
  27. Dyken P. R. Subacute sclerosing panencephalitis. Current status. Neurol Clin. 1985 Feb;3(1):179–196. [PubMed] [Google Scholar]
  28. Dörig R. E., Marcil A., Chopra A., Richardson C. D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993 Oct 22;75(2):295–305. doi: 10.1016/0092-8674(93)80071-l. [DOI] [PubMed] [Google Scholar]
  29. Fujinami R. S., Oldstone M. B. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature. 1979 Jun 7;279(5713):529–530. doi: 10.1038/279529a0. [DOI] [PubMed] [Google Scholar]
  30. GREENFIELD J. G. Encephalitis and encephalomyelitis in England and Wales during the last decade. Brain. 1950 Jun;73(2):141–166. doi: 10.1093/brain/73.2.141. [DOI] [PubMed] [Google Scholar]
  31. Gascon G., Yamani S., Crowell J., Stigsby B., Nester M., Kanaan I., Jallu A. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev. 1993 Sep-Oct;15(5):346–355. doi: 10.1016/0387-7604(93)90120-w. [DOI] [PubMed] [Google Scholar]
  32. Green S. H., Wirtschafter J. D. Ophthalmoscopic findings in subacute sclerosing panencephalitis. Br J Ophthalmol. 1973 Oct;57(10):780–787. doi: 10.1136/bjo.57.10.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Grünewald T., Lampe J., Weissbrich B., Reichmann H. A 35-year-old bricklayer with hemimyoclonic jerks. Lancet. 1998 Jun 27;351(9120):1926–1926. doi: 10.1016/S0140-6736(98)04091-4. [DOI] [PubMed] [Google Scholar]
  34. Gökçil Z., Odabaşi Z., Aksu A., Vural O., Yardim M. Acute fulminant SSPE: clinical and EEG features. Clin Electroencephalogr. 1998 Jan;29(1):43–48. doi: 10.1177/155005949802900112. [DOI] [PubMed] [Google Scholar]
  35. Gürer Y. K., Kükner S., Sarica B. Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol. 1996 Jan;14(1):72–74. doi: 10.1016/0887-8994(95)00257-x. [DOI] [PubMed] [Google Scholar]
  36. Haddad F. S., Risk W. S. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study. Ann Neurol. 1980 Feb;7(2):185–188. doi: 10.1002/ana.410070216. [DOI] [PubMed] [Google Scholar]
  37. Halsey N. A., Modlin J. F., Jabbour J. T., Dubey L., Eddins D. L., Ludwig D. D. Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol. 1980 Apr;111(4):415–424. doi: 10.1093/oxfordjournals.aje.a112916. [DOI] [PubMed] [Google Scholar]
  38. Hirano A., Ayata M., Wang A. H., Wong T. C. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J Virol. 1993 Apr;67(4):1848–1853. doi: 10.1128/jvi.67.4.1848-1853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hirano A. Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence. J Virol. 1992 Apr;66(4):1891–1898. doi: 10.1128/jvi.66.4.1891-1898.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Horta-Barbosa L., Fuccillo D. A., Sever J. L., Zeman W. Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature. 1969 Mar 8;221(5184):974–974. doi: 10.1038/221974a0. [DOI] [PubMed] [Google Scholar]
  41. Hosoya M., Shigeta S., Mori S., Tomoda A., Shiraishi S., Miike T., Suzuki H. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 2001 Mar;45(3):943–945. doi: 10.1128/AAC.45.3.943-945.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ikeda K., Akiyama H., Kondo H., Arai T., Arai N., Yagishita S. Numerous glial fibrillary tangles in oligodendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles. Neurosci Lett. 1995 Jul 14;194(1-2):133–135. doi: 10.1016/0304-3940(95)11713-7. [DOI] [PubMed] [Google Scholar]
  43. Jabbour J. T., Duenas D. A., Sever J. L., Krebs H. M., Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. JAMA. 1972 May 15;220(7):959–962. [PubMed] [Google Scholar]
  44. Jones C. E., Dyken P. R., Huttenlocher P. R., Jabbour J. T., Maxwell K. W. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients. Lancet. 1982 May 8;1(8280):1034–1037. doi: 10.1016/s0140-6736(82)92097-9. [DOI] [PubMed] [Google Scholar]
  45. Katayama Y., Kohso K., Nishimura A., Tatsuno Y., Homma M., Hotta H. Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol. 1998 Jan;36(1):299–301. doi: 10.1128/jcm.36.1.299-301.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Katz M. Clinical spectrum of measles. Curr Top Microbiol Immunol. 1995;191:1–12. doi: 10.1007/978-3-642-78621-1_1. [DOI] [PubMed] [Google Scholar]
  47. Kirk J., Zhou A. L., McQuaid S., Cosby S. L., Allen I. V. Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: ultrastructural and in situ hybridization evidence. Neuropathol Appl Neurobiol. 1991 Aug;17(4):289–297. doi: 10.1111/j.1365-2990.1991.tb00726.x. [DOI] [PubMed] [Google Scholar]
  48. Kuroiwa Y., Celesia G. G. Clinical significance of periodic EEG patterns. Arch Neurol. 1980 Jan;37(1):15–20. doi: 10.1001/archneur.1980.00500500045005. [DOI] [PubMed] [Google Scholar]
  49. Lakshmi V., Malathy Y., Rao R. R. Serodiagnosis of subacute sclerosing panencephalitis by enzyme linked immunosorbent assay. Indian J Pediatr. 1993 Jan-Feb;60(1):37–41. doi: 10.1007/BF02860504. [DOI] [PubMed] [Google Scholar]
  50. Lawrence D. M., Patterson C. E., Gales T. L., D'Orazio J. L., Vaughn M. M., Rall G. F. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol. 2000 Feb;74(4):1908–1918. doi: 10.1128/jvi.74.4.1908-1918.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. McQuaid S., Allen I. V., McMahon J., Kirk J. Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol. 1994 Apr;20(2):103–110. doi: 10.1111/j.1365-2990.1994.tb01168.x. [DOI] [PubMed] [Google Scholar]
  52. McQuaid S., Kirk J., Zhou A. L., Allen I. V. Measles virus infection of cells in perivascular infiltrates in the brain in subacute sclerosing panencephalitis: confirmation by non-radioactive in situ hybridization, immunocytochemistry and electron microscopy. Acta Neuropathol. 1993;85(2):154–158. doi: 10.1007/BF00227762. [DOI] [PubMed] [Google Scholar]
  53. McQuaid S., McMahon J., Herron B., Cosby S. L. Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol. 1997 Jun;23(3):218–224. [PubMed] [Google Scholar]
  54. Mehta P. D., Kane A., Thormar H. Quantitation of measles virus-specific immunoglobulins in serum, CSF, and brain extract from patients with subactue sclerosing panencephalitis. J Immunol. 1977 Jun;118(6):2254–2261. [PubMed] [Google Scholar]
  55. Mehta P. D., Thormar H., Kulczycki J., Wisniewski H. M. Immune response in subacute sclerosing panencephalitis. Ann N Y Acad Sci. 1994 Jun 6;724:378–384. doi: 10.1111/j.1749-6632.1994.tb38935.x. [DOI] [PubMed] [Google Scholar]
  56. Miller C., Farrington C. P., Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol. 1992 Oct;21(5):998–1006. doi: 10.1093/ije/21.5.998. [DOI] [PubMed] [Google Scholar]
  57. Modi G., Campbell H., Bill P. Subacute sclerosing panencephalitis. Changes on CT scan during acute relapse. Neuroradiology. 1989;31(5):433–434. doi: 10.1007/BF00343870. [DOI] [PubMed] [Google Scholar]
  58. Modlin J. F., Halsey N. A., Eddins D. L., Conrad J. L., Jabbour J. T., Chien L., Robinson H. Epidemiology of subacute sclerosing panencephalitis. J Pediatr. 1979 Feb;94(2):231–236. doi: 10.1016/s0022-3476(79)80829-x. [DOI] [PubMed] [Google Scholar]
  59. Nagano I., Nakamura S., Yoshioka M., Kogure K. Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology. 1991 Oct;41(10):1639–1642. doi: 10.1212/wnl.41.10.1639. [DOI] [PubMed] [Google Scholar]
  60. Norrby E., Kristensson K. Measles virus in the brain. Brain Res Bull. 1997;44(3):213–220. doi: 10.1016/s0361-9230(97)00139-1. [DOI] [PubMed] [Google Scholar]
  61. Nunes M. L., da Costa J. C., da Silva L. F. Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis. Pediatr Neurol. 1995 Sep;13(2):153–156. doi: 10.1016/0887-8994(95)00145-6. [DOI] [PubMed] [Google Scholar]
  62. Oya T., Martinez A. J., Jabbour J. T., Lemmi H., Duenas D. A. Subacute sclerosing panencephalitis. Correlation of clinical, neurophysiologic and neuropathologic findings. Neurology. 1974 Mar;24(3):211–218. doi: 10.1212/wnl.24.3.211. [DOI] [PubMed] [Google Scholar]
  63. Panitch H. S., Gomez-Plascencia J., Norris F. H., Cantell K., Smith R. A. Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon. Neurology. 1986 Apr;36(4):562–566. doi: 10.1212/wnl.36.4.562. [DOI] [PubMed] [Google Scholar]
  64. Park D. W., Boldt H. C., Massicotte S. J., Akang E. E., Roos K. L., Bodnar A., Pless J., Ghetti B., Pascuzzi R. M. Subacute sclerosing panencephalitis manifesting as viral retinitis: clinical and histopathologic findings. Am J Ophthalmol. 1997 Apr;123(4):533–542. doi: 10.1016/s0002-9394(14)70179-5. [DOI] [PubMed] [Google Scholar]
  65. PeBenito R., Naqvi S. H., Arca M. M., Schubert R. Fulminating subacute sclerosing panencephalitis: case report and literature review. Clin Pediatr (Phila) 1997 Mar;36(3):149–154. doi: 10.1177/000992289703600306. [DOI] [PubMed] [Google Scholar]
  66. Radhakrishnan K., Thacker A. K., Maloo J. C., Gerryo S. E., Mousa M. E. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology. 1988;7(3):159–164. doi: 10.1159/000110150. [DOI] [PubMed] [Google Scholar]
  67. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991 Jul;37(7):1153–1160. [PubMed] [Google Scholar]
  68. Risk W. S., Haddad F. S. The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from the Middle East. Arch Neurol. 1979 Oct;36(10):610–614. doi: 10.1001/archneur.1979.00500460044004. [DOI] [PubMed] [Google Scholar]
  69. Robertson W. C., Jr, Clark D. B., Markesbery W. R. Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Ann Neurol. 1980 Oct;8(4):422–425. doi: 10.1002/ana.410080414. [DOI] [PubMed] [Google Scholar]
  70. Saha V., John T. J., Mukundan P., Gnanamuthu C., Prabhakar S., Arjundas G., Sayeed Z. A., Kumaresan G., Srinivas K. High incidence of subacute sclerosing panencephalitis in south India. Epidemiol Infect. 1990 Feb;104(1):151–156. doi: 10.1017/s0950268800054637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Salmi A. A., Norrby E., Panelius M. Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun. 1972 Sep;6(3):248–254. doi: 10.1128/iai.6.3.248-254.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Santoshkumar B., Radhakrishnan K. Substantial spontaneous long-term remission in subacute sclerosing panencephalitis (SSPE). J Neurol Sci. 1998 Jan 21;154(1):83–88. doi: 10.1016/s0022-510x(97)00303-1. [DOI] [PubMed] [Google Scholar]
  73. Schmid A., Spielhofer P., Cattaneo R., Baczko K., ter Meulen V., Billeter M. A. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology. 1992 Jun;188(2):910–915. doi: 10.1016/0042-6822(92)90552-z. [DOI] [PubMed] [Google Scholar]
  74. Sidhu M. S., Crowley J., Lowenthal A., Karcher D., Menonna J., Cook S., Udem S., Dowling P. Defective measles virus in human subacute sclerosing panencephalitis brain. Virology. 1994 Aug 1;202(2):631–641. doi: 10.1006/viro.1994.1384. [DOI] [PubMed] [Google Scholar]
  75. Singer C., Lang A. E., Suchowersky O. Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature. Mov Disord. 1997 May;12(3):342–353. doi: 10.1002/mds.870120313. [DOI] [PubMed] [Google Scholar]
  76. Thiel A., Nau R., Fischer F., Meden H., Harms K., Weissbrich B., Prange H. Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy. Neurology. 1996 Dec;47(6):1604–1604. doi: 10.1212/wnl.47.6.1604. [DOI] [PubMed] [Google Scholar]
  77. Tomoda A., Shiraishi S., Hosoya M., Hamada A., Miike T. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol. 2001 Jan;24(1):54–59. doi: 10.1016/s0887-8994(00)00233-2. [DOI] [PubMed] [Google Scholar]
  78. Tourtellotte W. W., Ma B. I., Brandes D. B., Walsh M. J., Potvin A. R. Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Ann Neurol. 1981 Jun;9(6):551–556. doi: 10.1002/ana.410090607. [DOI] [PubMed] [Google Scholar]
  79. Tuncay R., Akman-Demir G., Gökyigit A., Eraksoy M., Barlas M., Tolun R., Gürsoy G. MRI in subacute sclerosing panencephalitis. Neuroradiology. 1996 Oct;38(7):636–640. doi: 10.1007/s002340050323. [DOI] [PubMed] [Google Scholar]
  80. Wirguin I., Steiner I., Kidron D., Brenner T., Udem S., Rager B., Abramsky O. Fulminant subacute sclerosing panencephalitis in association with pregnancy. Arch Neurol. 1988 Dec;45(12):1324–1325. doi: 10.1001/archneur.1988.00520360042009. [DOI] [PubMed] [Google Scholar]
  81. Yaqub B. A. Subacute sclerosing panencephalitis (SSPE): early diagnosis, prognostic factors and natural history. J Neurol Sci. 1996 Aug;139(2):227–234. [PubMed] [Google Scholar]
  82. Zilber N., Kahana E. Environmental risk factors for subacute sclerosing panencephalitis (SSPE). Acta Neurol Scand. 1998 Jul;98(1):49–54. doi: 10.1111/j.1600-0404.1998.tb07377.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES